Login / Signup

Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis.

Anna-Janina StephanMarion de LepperRegine WölleAgnes LuzakWei WangChristian JacobKim Maren SchneiderHorst BuxmannRangmar GoelzKlaus HamprechtPeter KummerSusanne ModrowWolfgang GreinerMiriam Reuschenbach
Published in: Cost effectiveness and resource allocation : C/E (2023)
cCMV comprises a considerable economic burden for the German healthcare system (€19,646 to €33,818 higher mean costs for infants with recorded cCMV diagnosis in the first year of life). Attempts should be made to reduce this burden.
Keyphrases
  • healthcare
  • health insurance
  • epstein barr virus
  • risk factors
  • adverse drug